Vaccine Monitor: 6 in 10 Parents of Teens and One-Third of Parents of 5-11 Year-Olds Say Their Child is Vaccinated for COVID-19, Both Up Since November February 1, 2022 News Release 3 in 10 of Those with Children Under 5 Expect to Get Them a Shot Right Away Once Eligible 1 in 4 Parents Say Their Student Had to Quarantine in January Due to COVID-19 Infection or Exposure; Overall 4 in 10 Report Some Education Disruption Growing shares of parents say…
KFF COVID-19 Vaccine Monitor: January 2022 Parents And Kids Update February 1, 2022 Poll Finding This Vaccine Monitor survey finds an increase in the share of parents reporting their child has received a COVID-19 vaccine, with 61% of parents of 12-17-year olds and 33% of 5-11-year-olds now saying their child has gotten at least one shot. Three in ten parents of children under the age of 5, a group that has not yet been approved to get a vaccine, say they’ll get their child vaccinated right away.
Community Health Centers Are A Key Source of COVID-19 Rapid At-Home Self-Tests For Hard-To-Reach Groups January 31, 2022 Blog As part of an effort to promote equitable access to tests, the Biden administration launched a testing supply program that has set aside 25 million rapid at-home self-test kits for distribution by community health centers. Under the program, health centers will be distributing self-tests to patients and community members, with a focus on populations at greatest risk from adverse outcomes related to COVID-19.
Marketplace Sign-ups Increased by 21% in 2022 January 28, 2022 Slide Forty-seven states saw Marketplace enrollment increase, ranging from 1% in Rhode Island to 42% in Texas. In 20 states, enrollment increased by more than 20%.
42% of Adults, and 70% of Those Likely Booster-Eligible, Now Say They’ve Gotten a COVID-19 Booster Shot; The Share Who Received At Least One Dose Inches Up to 77% in Omicron’s Wake January 28, 2022 News Release 6 in 10 Who Tried to Purchase an At-Home Test and a Third Who Sought an In-Person Test Say It Was Difficult to Find, Though Most Were Eventually Able to Get a Test Black and Hispanic Adults are More Likely Than White Adults to Worry About Omicron’s Effects, Including Becoming…
KFF COVID-19 Vaccine Monitor: January 2022 January 28, 2022 Poll Finding This report shows that 42% of all adults have received a COVID-19 booster, including about 70% of those who are likely booster-eligible. More than three quarters (77%) have received at least one dose of a COVID-19 vaccine. The poll also explores the public’s experiences getting at-home and in-person COVID-19 tests and other issues.
What to Watch in Medicaid Section 1115 Waivers One Year into the Biden Administration January 27, 2022 Issue Brief Section 1115 demonstration waivers provide states an avenue to test new approaches in Medicaid and generally reflect changing priorities from one presidential administration to another. This issue brief summarizes waiver priorities and actions under the Biden Administration as well as pending waiver themes and other issues to watch. If the Build Back Better Act (BBBA) fails to pass or is narrowed significantly, Medicaid waivers and other administrative actions may be a key tool for the Biden Administration to advance policy priorities absent legislation.
Funding for Health Care Providers During the Pandemic: An Update January 27, 2022 Issue Brief This brief describes the main sources of federal funding for hospitals and other health care providers during the pandemic, including how those funds have been allocated.
Millions of Medicare Beneficiaries Use Prescription Drugs That Could Be Subject to Price Negotiation, But Build Back Better Act Provision Exempts Many Drugs With High Federal Spending January 27, 2022 News Release Twenty drugs and dozens of insulin products used by 8.5 million Medicare beneficiaries would be subject to government drug price negotiation if the Build Back Better Act (BBBA) were enacted and fully implemented in 2022, according to a new KFF analysis. The 20 drugs include 18 drugs available to beneficiaries…
Simulating the Impact of the Drug Price Negotiation Proposal in the Build Back Better Act January 27, 2022 Issue Brief The Build Back Better Act (BBBA) includes a range of health and other proposals supported by President Biden, including a proposal to allow the federal government to negotiate the price of some prescription drugs covered under Medicare Part B (administered by physicians) and Medicare Part D (retail outpatient drugs). This brief illustrates the potential scope of the drug price negotiation proposal in the BBBA. This analysis is designed to highlight the types of Medicare-covered drugs that could be subject to negotiation, and which of the current top-spending drugs covered by Part B and Part D could be subject to price negotiation, and in what years, if the BBBA is enacted.